ライフサイエンスコーパス: valvuloplasty

1 therapy (which often included balloon aortic valvuloplasty).

2 ry (bioprosthesis replacement, valve repair, valvuloplasty).

3 ten benefit from percutaneous balloon mitral valvuloplasty.

4 onse to the transient hypotension induced by valvuloplasty.

5 re and 20 to 30 min after undergoing balloon valvuloplasty.

6 79 (39%) plug closure, and 35 (18%) balloon valvuloplasty.

7 atheter aortic valve implantation or balloon valvuloplasty.

8 tricular (BV) circulation after fetal aortic valvuloplasty.

9 valve replacement (TAVR), and balloon aortic valvuloplasty.

10 s, TAVI was performed without aortic balloon valvuloplasty.

11 may become the standard approach for mitral valvuloplasty.

12 fants and neonates is trans-catheter balloon valvuloplasty.

13 ented in any of the patients after tricuspid valvuloplasty.

14 eatment, which often included balloon aortic valvuloplasty.

15 ion were assessed before and after tricuspid valvuloplasty.

16 unction both at baseline and after tricuspid valvuloplasty.

17 moderate MR tended to improve without mitral valvuloplasty.

18 II as plug (33, 42%), and a True balloon for valvuloplasty (20, 56%).

19 e), an additional 86 aortic and 16 pulmonary valvuloplasties, 37 atrial septal cases, and 6 unclassif

20 Technically successful aortic valvuloplasty alters left heart valvar growth in fetuses

21 lts are obtained with trans-catheter balloon valvuloplasty, although stenosis resistant to further ba

22 and therapeutic purposes, including balloon valvuloplasties and electrophysiologic ablation procedur

23 al among patients who underwent fetal aortic valvuloplasty and achieved a BV circulation postnatally

24 dy sought to compare outcomes after surgical valvuloplasty and balloon dilation of the aortic valve i

25 ty of established procedures such as balloon valvuloplasty and coarctation angioplasty.

26 Percutaneous balloon mitral valvuloplasty and durable mitral prostheses have made th

27 Mitral valvuloplasty and radiofrequency ablation for AF, which

28 long-term studies of trans-catheter balloon valvuloplasty and surgical valvotomy warrant a review of

29 is, having the relief of stenosis by balloon valvuloplasty and undergoing initial treatment as a neon

30 tral valvuloplasty, antegrade balloon aortic valvuloplasty, and ablation of arrhythmias in the LA.

31 All eight patients underwent tricuspid valvuloplasty, and all experienced a decrease in regurgi

32 r in the body time, rapid pacing used during valvuloplasty, and repositioning of the prosthesis.

33 ion of the ductus arteriosus, balloon aortic valvuloplasty, and stenting or angioplasty of Blalock-Ta

34 and 177 (64.6%) treated with balloon aortic valvuloplasty; and group 2 (surgical): 88 (24.3%).

35 We performed benchtop testing of valvuloplasty, angioplasty, and sizing balloons as count

36 formed for procedures such as balloon mitral valvuloplasty, antegrade balloon aortic valvuloplasty, a

37 of patent ductus arteriosus (PDA); pulmonary valvuloplasty; aortic valvuloplasty; coarctation of the

38 ng a surgical AV procedure or aortic balloon valvuloplasty at Children's Hospital of Oklahoma between

39 g mid-term and long-term results for balloon valvuloplasty, balloon atrial septostomy and pulmonary a

40 (AoV) surgery after neonatal balloon aortic valvuloplasty (BAV) and characterize clinical outcomes o

41 Balloon aortic valvuloplasty (BAV) has become the first-line treatment

42 R) led to renewed interest in balloon aortic valvuloplasty (BAV).

43 unexpected death (SUD) after balloon aortic valvuloplasty (BAVP) for congenital aortic stenosis (AS)

44 Transcatheter balloon aortic valvuloplasty (BAVP) has become the first-line treatment

45 tion in LV pressure load with balloon aortic valvuloplasty (BAVP) may improve diastolic function.

46 Balloon mitral valvuloplasty (BMV) for mitral stenosis is a procedure t

47 immediately before and after balloon mitral valvuloplasty (BMV).

48 nts for congenital MS include balloon mitral valvuloplasty (BMVP), surgical mitral valvuloplasty (SMV

49 Fetal aortic valvuloplasty can be performed for severe midgestation a

50 Fetal aortic valvuloplasty carries a risk of fetal demise.

51 iosus (PDA); pulmonary valvuloplasty; aortic valvuloplasty; coarctation of the aorta angioplasty and

52 Mitral valvuloplasty, consisting of cleft repair (n = 10), and

53 Tricuspid valvuloplasty during either the hemi-Fontan or Fontan st

54 Fetal aortic valvuloplasty (FAV) can resolve outflow obstruction and

55 Fetal aortic valvuloplasty (FAV) may prevent progression of midgestat

56 After valvuloplasty, Fick-derived oxygen delivery increased by

57 2008, 70 fetuses underwent attempted aortic valvuloplasty for critical aortic stenosis with evolving

58 icular versus biventricular) of fetal aortic valvuloplasty for fetal aortic stenosis with evolving HL

59 uded 100 patients who underwent fetal aortic valvuloplasty for severe midgestation aortic stenosis wi

60 ur at 16 months of age and underwent balloon valvuloplasty for severe valvular aortic stenosis.

61 Transcatheter balloon valvuloplasty for the treatment of aortic and pulmonary

62 four patients studied both before and after valvuloplasty, for a total of 21 studies.

63 cases entered, 245 underwent FCI: 100 aortic valvuloplasties from a previous single-center report (ex

64 00 consecutive patients who underwent mitral valvuloplasty from 1987 to 1999.

65 The medical/balloon aortic valvuloplasty group had a higher New York Heart Associat

66 The medical/balloon aortic valvuloplasty group had significantly higher clinical ri

67 ays, mortality in the medical/balloon aortic valvuloplasty group was 102 (37.2%), and during median f

68 had experienced less previous balloon aortic valvuloplasty, had higher left ventricular ejection frac

69 Balloon aortic valvuloplasty has generally been the first-line therapy

70 s in patients with critical PS after balloon valvuloplasty has not clearly been defined.

71 Fetal balloon valvuloplasty has shown promise.

72 New advances such as fetal balloon valvuloplasty, improvements in the Ross technique, and l

73 umented improved outcomes following surgical valvuloplasty in a subset of patients who achieve tri-le

74 es increased in size after balloon pulmonary valvuloplasty in both groups at a rate that paralleled o

75 After balloon pulmonary valvuloplasty in infants with critical and severe PS, ri

76 en cardiac output was improved after balloon valvuloplasty in patients with aortic stenosis.

77 etermine (1) whether V O2 is increased after valvuloplasty in patients with mitral stenosis, and (2)

78 Balloon pulmonary valvuloplasty is considered first-line therapy for pulmo

79 although transcatheter aortic valvuloplasty is effective for relief of congenital AS,

80 While availability of fetal balloon valvuloplasty is limited, it has promise for promoting i

81 Percutaneous balloon valvuloplasty is the treatment of choice for patients in

82 ere aortic and pulmonary stenoses by balloon valvuloplasty may diminish their postnatal expression.

83 Prenatal balloon aortic valvuloplasty may improve left heart growth and function

84 Fetal aortic valvuloplasty may prevent progression of aortic stenosis

85 Reports of mitral valvuloplasty (MVP) in such patients are few; the altern

86 n fetuses underwent pre-natal cardiac aortic valvuloplasty (n = 8) and/or atrial septal dilation/sten

87 ction (n=9), arch augmentation (n=5), mitral valvuloplasty (n=5), ventricular septal defect closure (

88 d in 51 patients, including aortic valvotomy/valvuloplasty (n=56), coarctation repair (n=21), subaort

89 ation techniques were pioneered with balloon valvuloplasty of pulmonic stenosis in infants.

90 Successful mitral valvuloplasty or replacement was documented by long-term

91 of any type, and particularly with tricuspid valvuloplasty or replacement.

92 o standard therapy (including balloon aortic valvuloplasty) or transfemoral transcatheter implantatio

93 and a greater number of aortic valve balloon valvuloplasties (p = 0.003).

94 By multivariate analysis, balloon valvuloplasty (p < 0.001) and treatment as a neonate (p

95 , 18 (25.9%) after plug, and 7 (21.9%) after valvuloplasty (P = 0.036).

96 atients with aortic regurgitation or balloon valvuloplasty patients (no correction).

97 utcome of repeat percutaneous mitral balloon valvuloplasty (PMV) for post-PMV mitral restenosis.

98 phic scoring systems for percutaneous mitral valvuloplasty (PMV) have limitations.

99 Percutaneous mitral balloon valvuloplasty (PMV) results in good immediate results, p

100 ients undergoing percutaneous mitral balloon valvuloplasty (PMV).

101 he NHLBI established the multicenter Balloon Valvuloplasty Registry in November 1987 to assess both s

102 t, Lung, and Blood Institute (NHLBI) Balloon Valvuloplasty Registry.

103 Balloon pulmonary valvuloplasty relieves PS but can cause late PR.

104 Surgical valvuloplasty remains the best approach to treat neonate

105 nction was assessed as fair before tricuspid valvuloplasty repair and improved to good in five of sev

106 year (P = 0.418), after redo-TAVI, plug, and valvuloplasty, respectively.

107 intervention vs. traditional balloon aortic valvuloplasty; shunt type in staged palliation for hypop

108 mitral valvuloplasty (BMVP), surgical mitral valvuloplasty (SMVP), and mitral valve replacement (MVR)

109 Hemodynamic data and balloon pulmonary valvuloplasty techniques were reviewed.

110 greater improvements in cardiac output after valvuloplasty than do patients with aortic stenosis, the

111 term results of transcatheter balloon aortic valvuloplasty, the preferred treatment for congenital ao

112 surgery; the benefit of percutaneous balloon valvuloplasty to mortality might be similar to that of s

113 physiology, lack of prior balloon pulmonary valvuloplasty, use of drug-eluting stent, and increased

114 ntervention at 5 years was 27% after balloon valvuloplasty versus 65% after surgery.

115 Balloon pulmonary valvuloplasty was successful in 64% of patients with cri

116 Fetuses undergoing in utero aortic valvuloplasty with an unfavorable multivariable threshol

117 Aortic valvuloplasty with porcine intestinal submucosa is assoc